Skip to main content
SpringerLink
Log in

Sarcomelicope alkaloids as leads for the discovery of new antitumor acronycine derivatives

  • Published:
Phytochemistry Reviews Aims and scope Submit manuscript

Abstract

The acridone alkaloid acronycine first isolated from Acronychia baueri Schott (Rutaceae) in 1948, was later shown to exhibit a promising activity against a broad spectrum of solid tumors. Nevertheless, clinical trials only gave poor results, probably due to the moderate potency and low water solubility of this alkaloid. Early studies on structure-activity relationships in the series concluded that the 1,2-double bond was an essential structural requirement to observe cytotoxic activity. It is the reason why the isolation in our laboratory of the unstable acronycine epoxide from several New-Caledonian Sarcomelicope species led to the hypothesis of bioactivation of acronycine by transformation of the 1,2-double bond into the corresponding oxirane in vivo. Consequently, there was interest in the search for acronycine derivatives modified in the pyran ring and having improved stability, but a similar reactivity toward nucleophilic agents as acronycine epoxide. Accordingly, we synthesized a series of cis- and trans-1,2-dihydroxy-1,2-dihydroacronycine diesters which exhibited interesting antitumor properties with a broadened spectrum of activity and increased potency when compared with acronycine. (±)-Cis-1,2-diacetoxy-1,2-dihydroacronycine was of particular interest, due to its marked activity in vivo against the resistant solid tumor C 38 colon carcinoma. The demonstration that acronycine should interact with DNA by some noncovalent process able to stabilize the double helix against thermal denaturation prompted us to develop benzo[b]acronycine analogues possessing an additional aromatic ring linearly fused on the natural alkaloid basic skeleton. When tested against a panel of cancer cell lines in vitro, cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diesters exhibited cytotoxic activities within the same range of potency as the most active drugs currently used in cancer chemotherapy. In vivo, cis-1,2-diacetoxy-1,2-dihydrobenzo[b]acronycine (S23906-1), selected for further preclinical development, demonstated a marked antitumor activity in human orthotopic models of lung, ovarian and colon cancers xenografted in nude mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Brum-Bousquet M, Mitaku S, Skaltsounis A-L, Tillequin F & Koch M (1988) Acronycine epoxide: a new acridone alkaloid from several Sarcomelicope species. Planta Med., 54: 470–471.

    CAS  PubMed  Google Scholar 

  • Chou T-C, Tzeng C-C, Wu T-S, Watanabe KA & Su T-L (1989) Inhibition of cell growth and macromolecule biosynthesis of human promyelocytic leukemic cells by acridone alkaloids. Phytother. Res., 3: 237–242.

    CAS  Google Scholar 

  • Costes N, Michel S, Tillequin F, Koch M, Pierré A & Atassi Gh (1999) Chiral dihydroxylation of acronycine: Absolute con-figuration of natural cis-1,2-dihydroxy-1,2-dihydroacronycine and cytotoxicity of (1R,2R)-and (1S,2S)-1,2-diacetoxy-1,2-dihydroacronycine. J. Nat. Prod., 62: 490–492.

    Article  PubMed  CAS  Google Scholar 

  • Costes N, Le Deit H, Michel S, Tillequin F, Koch M, Pfeiffer B, Renard P, Léonce S, Guilbaud N, Kraus-Berthier L, Pierré A & Atassi Gh (2000) Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h]acridin-7-one analogs of acronycine. J. Med. Chem., 43: 2395–2402.

    Article  PubMed  CAS  Google Scholar 

  • Dorr RT Liddil JD (1988) Development of a parenteral formulation of the antitumour agent acronycine. J. Drug Dev., 1: 31–39.

    Google Scholar 

  • Dorr RT, Liddil JD, Von Hoff DD, Soble M & Osborne CK (1989) Antitumor activity and murine pharmacokinetics of parenteral acronycine. Cancer Res., 49: 340–344.

    PubMed  CAS  Google Scholar 

  • Elomri A, Mitaku S, Michel S, Skaltsounis A-L, Tillequin F, Koch M, Pierré A, Guilbaud N, Léonce S, Kraus-Berthier L, Rolland Y, & Atassi Gh (1996) Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series. J. Med. Chem., 39: 4762–4766.

    Article  PubMed  CAS  Google Scholar 

  • Fokialakis N, Mitaku S, Mikros E, Skaltsounis A-L, Tillequin F & Sévenet T (1999) Megistosarcimine and megistosarconine, two alkaloids from Sarcomelicope megistophylla. Phytochemistry, 52: 1745–1748.

    Article  PubMed  CAS  Google Scholar 

  • Fokialakis N, Magiatis P, Skaltsounis A-L, Tillequin F & Sévenet T (2000a) Structure of sarcomeginine: an application of long range 1H-15N correlation at natural abundance. J. Nat. Prod., 63: 1004–1005.

    Article  PubMed  CAS  Google Scholar 

  • Fokialakis N, Magiatis P, Skaltsounis A-L, Tillequin F & Sévenet T (2000b) Megistolactone, a new alkaloid from Sarcomelicope megistophylla. Z. Naturforsch., 55C: 874–876.

    Google Scholar 

  • Fokialakis N, Magiatis P, Aligiannis N, Mitaku S, Tillequin F, Skaltsounis A-L & Sévenet T (2001a) Furomegistines I and II, two new alkaloids from the bark of Sarcomelicope megistophylla. Phytochemistry, 57: 593–596.

    Article  PubMed  CAS  Google Scholar 

  • Fokialakis N, Magiatis P, Terzis A, Tillequin F & Skaltsounis A-L (2001b) Cyclomegistine, the first alkaloid with the new cyclobuta[b]quinoline ring system from Sarcomelicope megistophylla. Tetrahedron Lett., 42: 5323–5325.

    Article  CAS  Google Scholar 

  • Gougoutas JZ & Kaski BA (1970) The crystal and molecular structure of bromodihydroacronycine. Acta Cryst., B26: 853–859.

    Google Scholar 

  • Govindachari TR, Pai BR & Subramaniam PS (1966) Alkaloids of Glycosmis pentaphylla (Retz.) Correa. Tetrahedron, 22: 3245–3252.

    Article  CAS  Google Scholar 

  • Guilbaud N, Kraus-Berthier L, Meyer-Losic F, Malivet V, Chacun C, Jan M, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi Gh, Hickman JA & Pierré A (2001) Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human tumors. Clin. Cancer Res., 7: 2573–2580.

    PubMed  CAS  Google Scholar 

  • Guilbaud N, Léonce S, Tillequin F, Koch M, Hickman JA & Pierré A (2002) Acronycine derivatives as promising antitumor agents. Anti-Cancer Drugs, 13: 445–449.

    Article  PubMed  CAS  Google Scholar 

  • Hartley TG (1974) A revision of the genus Acronychia (Rutaceae). J. Arnold Arbor., 55: 469–567.

    Google Scholar 

  • Hartley TG (1975) The taxonomic status of the genus Bauerella (Rutaceae). J. Arnold Arbor., 56: 164–170.

    Google Scholar 

  • Hartley TG (1982) A revision of the genus Sarcomelicope (Rutaceae). Aust. J. Bot., 30: 359–372.

    Article  Google Scholar 

  • Hartley TG (1986) Three new species of Sarcomelicope (Rutaceae) from New Caledonia (with a new key to the species of the genus). Adansonia, 8: 183–189.

    Google Scholar 

  • Hlubucek J, Ritchie E & Taylor WC (1970) A synthesis of acronycine. Aust. J. Chem., 23: 1881–1889.

    Article  CAS  Google Scholar 

  • Hughes GK Lahey FN, Price JR & Webb LJ (1948) Alkaloids of the Australian Rutaceae. Nature, 162: 223–224.

    CAS  PubMed  Google Scholar 

  • Léonce S, Pérez V, Lambel S, Peyroulan D, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi Gh, Hickman JA & Pierré A (2001) Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906–1 precede the irreversible arrest of the tumor cells in S phase leading to apoptosis. Mol. Pharmacol, 60: 1383–1391.

    PubMed  Google Scholar 

  • Macdonald PL & Robertson AV (1966) The structure of acronycine. Aust. J. Chem., 19: 275–281.

    Article  CAS  Google Scholar 

  • Magiatis P, Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pierré A & Atassi Gh. (1998) Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series. J. Nat. Prod., 61: 198–201.

    Article  PubMed  CAS  Google Scholar 

  • Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pusset J. & Chauvière G (1986) Alcaloïdes de Sarcomelicope glauca. J.Nat. Prod., 49: 1091–1095.

    Article  CAS  Google Scholar 

  • Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pusset J. & Chauvière G. (1987) Four new acridone alkaloids from Sarcomelicope dogniensis Hartley (Rutaceae). Heterocycles, 26: 2057–2063.

    Article  CAS  Google Scholar 

  • Mitaku S, Skaltsounis A-L, Tillequin F, Koch M & Pusset J (1989) Alcaloïdes des écorces de Sarcomelicope dogniensis. Ann. Pharm. Fr., 47: 149–156.

    PubMed  CAS  Google Scholar 

  • Papageorgiou M, Fokialakis N, Skaltsounis A-L, Mitaku S, Tillequin F & Sévenet T (2000) Two new alkaloids from the bark of Sarcomelicope megistophylla. J. Nat. Prod., 63: 385–386.

    Article  PubMed  CAS  Google Scholar 

  • Reisch J & Wickramasinghe A (1990) Oxidation of acridone alkaloids: Synthesis of 5-methoxyacronycine. Monatsh. Chem., 121: 709–712.

    Article  CAS  Google Scholar 

  • Reisch J & Top M (1991) Wege zum Acronycin-Epoxid und Acronycin-Diol. Pharmazie, 46: 745.

    CAS  Google Scholar 

  • Reisch J & Schiwek K (1994) Synthese von Acronycinepoxid. Liebigs Ann. Chem., 317–318.

  • Scarffe JH, Beaumont AR & Crowther D (1983) Phase I-II evaluation of acronycine in patients with multiple myeloma. Cancer Treat. Rep., 67: 93–94.

    PubMed  CAS  Google Scholar 

  • Schneider J, Evans EL, Grunberg E & Fryer RI (1972) Synthesis and biological activity of acronycine analogs. J.Med. Chem., 15: 266–270.

    Article  PubMed  CAS  Google Scholar 

  • Su T-L & Watanabe KA (1993) Anticancer Acridone Alkaloids. In Studies in Natural Products Chemistry. (Vol. 13, pp. 347–382). In Rahman, A. & Basha F.Z. (Eds.). Amsterdam: Elsevier.

    Google Scholar 

  • Svoboda GH (1966) Alkaloids of Acronychia baueri (Bauerella australiana)-Extraction of the alkaloids and studies of structureactivity relationships. Lloydia, 29: 206–224.

    CAS  Google Scholar 

  • Svoboda GH, Poore GA, Simpson PJ & Boder GB (1966) Alkaloids of Acronychia baueri-Isolation of the alkaloids and study of the antitumor and other biological properties of acronycine. J. Pharm. Sci., 55: 758–768.

    PubMed  CAS  Google Scholar 

  • Tillequin F (1997) Alkaloids in the genus Sarcomelicope. Recent Res. Devel. Phytochem., 1: 675–687.

    Google Scholar 

  • Tillequin F (2002) Conception de nouveaux agents antotumoraux en série acronycine. Recent Res. Devel. Ann. Pharm. Fr., 60: 246–252.

    CAS  Google Scholar 

  • Tillequin F, Michel S & Skaltsounis A-L (1998) Acronycine-type Alkaloids: Chemistry and Biology. In Pelletier SW (Ed.), Alkaloids: Chemical and Biological Perspectives (Vol. 12, pp. 1–102). Oxford: Pergamon.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Pharmacognosie de l’Université René Descartes U.M.R./C.N.R.S. no. 8638, Faculté de Pharmacie, 4 Avenue de l’Observatoire, 75006, Paris, (France)

    François Tillequin

Authors
  1. François Tillequin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tillequin, F. Sarcomelicope alkaloids as leads for the discovery of new antitumor acronycine derivatives. Phytochemistry Reviews 1, 355–368 (2002). https://doi.org/10.1023/A:1026076825006

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026076825006

Search

Navigation